Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Molecular Oncology, Markers, Clinical Correlates

Comparison of Potential Markers of Farnesyltransferase Inhibition

Alex A. Adjei, Jenny N. Davis, Charles Erlichman, Phyllis A. Svingen and Scott H. Kaufmann
Alex A. Adjei
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jenny N. Davis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Erlichman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phyllis A. Svingen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott H. Kaufmann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published June 2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: February 2001 to January 2021

AbstractFull-text HTMLPDF
Total159935151903

Cited By

Article Information

Volume 6, Issue 6, pp. 2318-2325

PubMed 
10873082

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Accepted March 30, 2000
  • Received January 3, 2000
  • Revision received March 28, 2000
  • Published first June 1, 2000.

Copyright & Usage 
© 2000

Author Information

  1. Alex A. Adjei2,
  2. Jenny N. Davis,
  3. Charles Erlichman,
  4. Phyllis A. Svingen and
  5. Scott H. Kaufmann
  1. Divisions of Medical Oncology [A. A. A., C. E.] and Oncology Research [J. N. D., P. A. S., S. H. K.], Mayo Clinic and Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Graduate School [S. H. K.], Rochester, Minnesota 55905
    View Full Text
    PreviousNext
    Back to top
    June 2000
    Volume 6, Issue 6
    • Table of Contents

    Sign up for alerts

    View this article with LENS

    Open full page PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Clinical Cancer Research article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Comparison of Potential Markers of Farnesyltransferase Inhibition
    (Your Name) has forwarded a page to you from Clinical Cancer Research
    (Your Name) thought you would be interested in this article in Clinical Cancer Research.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Comparison of Potential Markers of Farnesyltransferase Inhibition
    Alex A. Adjei, Jenny N. Davis, Charles Erlichman, Phyllis A. Svingen and Scott H. Kaufmann
    Clin Cancer Res June 1 2000 (6) (6) 2318-2325;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Comparison of Potential Markers of Farnesyltransferase Inhibition
    Alex A. Adjei, Jenny N. Davis, Charles Erlichman, Phyllis A. Svingen and Scott H. Kaufmann
    Clin Cancer Res June 1 2000 (6) (6) 2318-2325;
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • INTRODUCTION
      • MATERIALS AND METHODS
      • RESULTS
      • DISCUSSION
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    Advertisement

    Related Articles

    Cited By...

    More in this TOC Section

    • Prognostic Impact of Hypoxia-Inducible Factors 1α and 2α in Colorectal Cancer Patients
    • Cyclooxygenase-2 Expression
    • Prognostic Relevance of Increased Angiogenesis in Osteosarcoma
    Show more Molecular Oncology, Markers, Clinical Correlates
    • Home
    • Alerts
    • Feedback
    • Privacy Policy
    Facebook  Twitter  LinkedIn  YouTube  RSS

    Articles

    • Online First
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts

    Info for

    • Authors
    • Subscribers
    • Advertisers
    • Librarians

    About Clinical Cancer Research

    • About the Journal
    • Editorial Board
    • Permissions
    • Submit a Manuscript
    AACR logo

    Copyright © 2021 by the American Association for Cancer Research.

    Clinical Cancer Research
    eISSN: 1557-3265
    ISSN: 1078-0432

    Advertisement